Homepage | Medicines Discovery Catapult

Innovation in medicine discovery science, to more rapidly benefit patients, lies at the heart of the strategy for the Medicines Discovery Catapult

If you liked c1cccnc1, you’ll love c1cncnc1

One of our collaborators, Intellegens, recently published a great paper in JCIM – Imputation of Assay Bioactivity Data Using Data Learning – focusing on applying Deep Learning approaches to tackle the problem of sparse data, a recurring issue in drug discovery. Sparse data typically arise when compounds are being assayed against multiple biological targets, but […]

A guide to sourcing biosamples

Medicines Discovery Catapult and the BioIndustry Association stated in their 2018 State of the Discovery Nation Report, that: “… over 80% of SMEs surveyed agreed that access to biosamples is hugely important for commercial development” and “… as many as 80% found accessing UK samples unexpectedly difficult…” A major recommendation of this report was that […]

Using AI in drug discovery

In recent years, machine learning and Artificial Intelligence (AI) have become widely popularised in all areas of modern life, and drug discovery is no exception. Why AI? The benefit of AI for detecting novel drug-target interactions, or even in silico design of novel drug-like compounds, is clear. The possible chemical search space of potentially synthesizable […]

The many ways charities can boost innovation in medical research

Among the wealth and diversity of stakeholders that bring science out of the laboratories and closer to patients, charities are usually regarded as the hands-off funders of research. However, an increasing number of biomedical research charities have been taking a more proactive and involved role in boosting innovation in the therapeutic areas they support. Action […]

"Putting the voice of patients at the heart of drug discovery is vital to develop the new targeted therapies of the future."

Chris Molloy, Chief Executive Officer

It can take 10-15 years to develop a new medicine at an estimated cost of £1.2bn

At the Medicines Discovery Catapult we aim to help UK SME biotechs, academics and innovators have access to the laboratory facilities, knowledge, data, technologies and networks they need to be able to progress their programmes of medicines research and development. Our objective is to work collaboratively as part of a Syndicate to bring new proven therapies to patients faster and more cost-effectively.

Partnership opportunities

Our position as an impartial not-for-profit organisation means we are uniquely placed to bring groups together from the private, public, academic and charitable sectors. We are able to offer these groups the facilities, expertise and tools that will ultimately make a real difference to the lives of patients. Organisations can also partner with us to help resolve particular short-term bottlenecks or problems including poor access to data and samples.

Find out more

We're recruiting

We’re now looking for talented scientists and technologists to join the Medicines Discovery Catapult team to help keep the UK at the forefront of medicines discovery. If you share our values and have the skills, drive and resilience to be part of an organisation looking to move the UK’s life sciences sector forward faster, we would be delighted to hear from you.

View our vacancies

Science & Technology

Informatics

Virtual R&D

Discovery Syndicates

Samples and Data